Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by High Frequency Deep Sclerotomy Hfds

Research Leaders

6 sponsors active, led by Duke University

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Early Phase 1 (1)
Phase 2/3 (1)

Trial Status

Unknown2
Withdrawn1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • High Frequency Deep Sclerotomy Hfds1
  • Aflibercept1
  • Mitomycin1
  • Dextenza 04mg Ophthalmic Insert1
  • Prednisolone Acetate1

Active Sponsors

  • Duke University1
  • Medical University of Lublin1
  • National Taiwan University Hospital Hsin-Chu Branch1
  • Ocular Therapeutix, Inc.1
  • Medical University of Vienna1

Top Investigators

Related Conditions

  • Primary Open Angle Glaucoma1
  • Cataract Surgery1
  • Intraocular Pressure1
  • Optic Nerve Damage1
  • Efficacy Self1

Activity Timeline